LungLife AI, INC
Develops AI-enhanced blood tests to evaluate indeterminate lung nodules for early cancer detection.
LLAI | IL
Overview
Corporate Details
- ISIN(s):
- USU5500L1045 (+1 more)
- LEI:
- 549300VBVDIF0Y3OVI38
- Country:
- United States of America
- Address:
- 850 New Burton Road Suite 201, 19904 Dover
- Website:
- https://lunglifeai.com
- Sector:
- Human health and social work activities
- Industry:
- Other residential care activities
Description
LungLife AI, Inc. is a developer of clinical diagnostic solutions focused on the early detection of lung cancer. The company's core product, the LungLB® test, is a minimally invasive, blood-based liquid biopsy enhanced by artificial intelligence. It is designed to provide clinicians with additional information to evaluate indeterminate lung nodules, aiding in informed management decisions. By analyzing biomarkers from a simple blood draw, LungLife AI aims to be a driving force in improving outcomes for patients through earlier and more accurate diagnosis. The company operates a CLIA-certified laboratory for processing its tests.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all LungLife AI, INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LungLife AI, INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LungLife AI, INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
